Stéphane Birklé

1.1k total citations
26 papers, 918 citations indexed

About

Stéphane Birklé is a scholar working on Molecular Biology, Neurology and Immunology. According to data from OpenAlex, Stéphane Birklé has authored 26 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Neurology and 13 papers in Immunology. Recurrent topics in Stéphane Birklé's work include Glycosylation and Glycoproteins Research (15 papers), Neuroblastoma Research and Treatments (14 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Stéphane Birklé is often cited by papers focused on Glycosylation and Glycoproteins Research (15 papers), Neuroblastoma Research and Treatments (14 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Stéphane Birklé collaborates with scholars based in France, United States and Taiwan. Stéphane Birklé's co-authors include Guichao Zeng, Robert K. Yu, Jacques Aubry, Luoyi Gao, L. Gao, François Paris, Denis Cochonneau, Nidia Alvarez-Rueda, Jacques Barbet and Sophie Fougeray and has published in prestigious journals such as PLoS ONE, Biochemistry and Clinical Cancer Research.

In The Last Decade

Stéphane Birklé

26 papers receiving 908 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stéphane Birklé France 17 651 364 247 218 152 26 918
Jean‐Philippe Brosseau Canada 14 604 0.9× 248 0.7× 182 0.7× 304 1.4× 35 0.2× 24 1.2k
Jacqueline Lesperance United States 16 819 1.3× 248 0.7× 46 0.2× 478 2.2× 48 0.3× 25 1.2k
Michal Šimíček Czechia 13 821 1.3× 132 0.4× 124 0.5× 284 1.3× 21 0.1× 29 1.1k
Dick J. Schol Netherlands 11 473 0.7× 152 0.4× 73 0.3× 218 1.0× 195 1.3× 13 734
Maike Busch Germany 13 465 0.7× 78 0.2× 247 1.0× 208 1.0× 48 0.3× 40 819
Evon Poon United Kingdom 14 789 1.2× 60 0.2× 334 1.4× 303 1.4× 41 0.3× 24 1.1k
Xihui Yang United States 10 774 1.2× 102 0.3× 71 0.3× 352 1.6× 123 0.8× 10 1.3k
Yoshihiro Otani Japan 15 373 0.6× 95 0.3× 63 0.3× 329 1.5× 186 1.2× 65 853
Karen E. DeBell United States 16 381 0.6× 366 1.0× 34 0.1× 113 0.5× 64 0.4× 24 743
Matti Autero Finland 14 662 1.0× 611 1.7× 22 0.1× 160 0.7× 132 0.9× 22 1.0k

Countries citing papers authored by Stéphane Birklé

Since Specialization
Citations

This map shows the geographic impact of Stéphane Birklé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Birklé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Birklé more than expected).

Fields of papers citing papers by Stéphane Birklé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Birklé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Birklé. The network helps show where Stéphane Birklé may publish in the future.

Co-authorship network of co-authors of Stéphane Birklé

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane Birklé. A scholar is included among the top collaborators of Stéphane Birklé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane Birklé. Stéphane Birklé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mortier, Erwan, et al.. (2023). Biology of GD2 ganglioside: implications for cancer immunotherapy. Frontiers in Pharmacology. 14. 1249929–1249929. 26 indexed citations
2.
Thomas, Pauline, et al.. (2021). CAR T Cell Therapy’s Potential for Pediatric Brain Tumors. Cancers. 13(21). 5445–5445. 12 indexed citations
3.
Kailayangiri, Sareetha, et al.. (2021). SIRPα-specific monoclonal antibody enables antibody-dependent phagocytosis of neuroblastoma cells. Cancer Immunology Immunotherapy. 71(1). 71–83. 13 indexed citations
4.
Fleurence, Julien, Sophie Fougeray, Émilie Pinault, et al.. (2019). Impairing temozolomide resistance driven by glioma stem‐like cells with adjuvant immunotherapy targeting O‐acetyl GD2 ganglioside. International Journal of Cancer. 146(2). 424–438. 25 indexed citations
5.
6.
Fougeray, Sophie, Ali El Roz, Julien Fleurence, et al.. (2017). Neuroblastoma chemotherapy can be augmented by immunotargeting O-acetyl-GD2 tumor-associated ganglioside. OncoImmunology. 7(1). e1373232–e1373232. 11 indexed citations
7.
Fleurence, Julien, Sophie Fougeray, Denis Cochonneau, et al.. (2017). TargetingO-Acetyl-GD2 Ganglioside for Cancer Immunotherapy. Journal of Immunology Research. 2017. 1–16. 30 indexed citations
8.
Fougeray, Sophie, Joël Fleurence, Denis Cochonneau, et al.. (2016). O-acetylated gangliosides: Structure, biosynthesis, immunogenicity, functions and their potential for cancer immunotherapy. HAL (Le Centre pour la Communication Scientifique Directe). 4(3). 21–30. 3 indexed citations
9.
Dorvillius, Mylène, Denis Cochonneau, Tanguy Chaumette, et al.. (2014). Chimeric Antibody c.8B6 to O-Acetyl-GD2 Mediates the Same Efficient Anti-Neuroblastoma Effects as Therapeutic ch14.18 Antibody to GD2 without Antibody Induced Allodynia. PLoS ONE. 9(2). e87210–e87210. 36 indexed citations
10.
Cochonneau, Denis, Alexis Michaud, Mylène Dorvillius, et al.. (2013). Cell cycle arrest and apoptosis induced by O-acetyl-GD2-specific monoclonal antibody 8B6 inhibits tumor growth in vitro and in vivo. Cancer Letters. 333(2). 194–204. 34 indexed citations
11.
Bessard, Anne, Denis Cochonneau, Géraldine Teppaz, et al.. (2013). Tumor targeting of the IL‐15 superagonist RLI by an anti‐GD2 antibody strongly enhances its antitumor potency. International Journal of Cancer. 133(3). 757–765. 60 indexed citations
12.
Birklé, Stéphane, Tanguy Chaumette, Marie‐Hélène Gaugler, et al.. (2013). Inhibition of tumor angiogenesis by globotriaosylceramide immunotargeting. OncoImmunology. 2(4). e23700–e23700. 6 indexed citations
13.
Chaumette, Tanguy, Marie‐Hélène Gaugler, Denis Cochonneau, et al.. (2012). Anti-Gb3 Monoclonal Antibody Inhibits Angiogenesis and Tumor Development. PLoS ONE. 7(11). e45423–e45423. 20 indexed citations
14.
Alvarez-Rueda, Nidia, Denis Cochonneau, Tanguy Chaumette, et al.. (2011). A Monoclonal Antibody to O-Acetyl-GD2 Ganglioside and Not to GD2 Shows Potent Anti-Tumor Activity without Peripheral Nervous System Cross-Reactivity. PLoS ONE. 6(9). e25220–e25220. 73 indexed citations
15.
Alvarez-Rueda, Nidia, Ghislaine Béhar, Virginie Ferré, et al.. (2006). Generation of llama single-domain antibodies against methotrexate, a prototypical hapten. Molecular Immunology. 44(7). 1680–1690. 76 indexed citations
16.
Birklé, Stéphane, Guichao Zeng, L. Gao, Robert K. Yu, & Jacques Aubry. (2003). Role of tumor-associated gangliosides in cancer progression. Biochimie. 85(3-4). 455–463. 195 indexed citations
17.
Birklé, Stéphane, Luoyi Gao, Guichao Zeng, & Robert K. Yu. (2000). Down‐Regulation of GD3 Ganglioside and Its O‐Acetylated Derivative by Stable Transfection with Antisense V. Journal of Neurochemistry. 74(2). 547–554. 42 indexed citations
18.
Birklé, Stéphane, et al.. (1999). Down‐Regulation of the Expression of O‐Acetyl‐GD3 by theO‐Acetylesterase cDNA in Hamster Melanoma Cells. Journal of Neurochemistry. 72(3). 954–961. 34 indexed citations
19.
Moutel, Sandrine, Stéphane Birklé, Valérie Laurence, et al.. (1997). Generation and Characterization of a Mouse Single-Chain Antibody Fragment Specific for Disialoganglioside (G D2 ). Hybridoma. 16(4). 335–346. 10 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Philippe Brosseau Breakdown of academic impact, for papers by Jacqueline Lesperance Breakdown of academic impact, for papers by Michal Šimíček Breakdown of academic impact, for papers by Dick J. Schol Breakdown of academic impact, for papers by Maike Busch Breakdown of academic impact, for papers by Evon Poon Breakdown of academic impact, for papers by Xihui Yang Breakdown of academic impact, for papers by Yoshihiro Otani Breakdown of academic impact, for papers by Karen E. DeBell Breakdown of academic impact, for papers by Matti Autero
Rankless by CCL
2026